Γ—

Netrin-1 Rescues Blood Stem Cells in Mice

This protein appears to be critical for the cell cycle and DNA repair.

Share







Blood cellsBlood cells

Scientists have discovered that the protein Netrin-1 alleviates the age-related decline in hematopoietic stem cell function in mice, enhancing HSC transplantation and protecting these mice from the harmful effects of chemotherapy [1].

To do this, we need your support. Your charitable contribution tranforms into rejuvenation research, news, shows, and more. Will you help?

(Not) a niche problem

Declining stem cell function (stem cell exhaustion) is linked to numerous aging phenotypes [2]. Stem cells reside in so-called β€œniches” – microenvironments whose role is to support stem cells’ viability and function. However, stem cell niches themselves are prone to accumulating age-related damage [3].

In this new study, the researchers β€œsought to determine whether aged blood stem cell function can be restored by rejuvenating their supportive niches within the bone marrow”. The health of hematopoietic stem cells, which give rise to differentiated blood cells, is especially important in the context of blood cancer, with patients often requiring hematopoietic stem cell transplantation (HSCT). HSCT effectiveness diminishes with age, probably due to age-related changes in the bone marrow niche, although the exact mechanisms of this deterioration remain unknown [4].

Target: Netrin-1

The researchers used a mouse model that recapitulates premature aging of the immune system. Transcriptomic analysis revealed multiple genes that were differentially expressed in this model compared to wild-type mice, and the researchers focused on the one that encodes Netrin-1. Since this protein has been linked to angiogenesis (blood vessel building) and osteogenesis (bone building), it seemed plausible that it might be relevant to the BM stem cell niche.

Perusing existing RNA sequencing databases revealed that in bone marrow, Netrin-1 is expressed mostly in mesenchymal stromal cells (MSCs) and epithelial cells (ECs), both of which are important components of the niche. Conditional deletion of Netrin-1 in those cells led to impaired vascular integrity and accumulation of adipocytes (fat cells), both of which are known features of BM niche aging.

More importantly, Netrin-1 deletion seemed to impair stem cell function. In mice with Netrin-1-deficient MSCs, more HSCs were β€œstuck” in the nonproliferative G0 phase of the cell cycle. This decrease in progenitor activity was accompanied by impaired engraftment capacity when HSCs from Netrin-1-deficient mice were transplanted into wild-type mice. In mice with Netrin-1 knocked down in ECs, similar effects were observed, albeit of a lesser magnitude. An increase in the number of quiescent stem cells and a decline in their engraftment capacity are characteristic of hematopoietic aging.

DNA damage responses restored

The researchers performed RNA sequencing to elucidate the effect of Netrin-1 deletion on gene expression. In MSCs and ECs of Netrin-1-deficient mice, they detected significant upregulation of pathways associated with adipogenesis, cell cycle, and, importantly, DNA damage responses (DDR). Consequently, those cells accumulated more DNA damage than controls.

Accumulation of DNA damage is central to cellular aging. In this experiment, DNA damage was greater in MSCs and ECs taken from aged wild-type mice than those taken from their young counterparts. Strikingly, a two-week Netrin-1 treatment was enough to significantly reverse DNA damage in aged mice. The treatment also resulted in improved bone marrow vascular health.

Protection from chemotherapy-induced damage

However, the important question was whether Netrin-1 supplementation would improve the function of an aged hematopoietic system, which it did. The treatment increased the number of functional HSCs following bone marrow transplantation four-fold. Moreover, HSCs from treated aged mice were almost as fit and competent as those derived from young controls.

The researchers also learned that not all beneficial effects of Netrin-1 supplementation on HSCs result from improvements in the bone marrow niche. Many of those effects were recapitulated when HSCs were co-cultured with Netrin-1 in vitro, showing that Netrin-1 probably exerts its benefits both directly and indirectly, via niche improvements.

Netrin-1 treatment also significantly protected mice from the detrimental effects of chemotherapy. Treated mice demonstrated preservation of body weight and much more robust hematopoietic recovery. When mice were subjected to an especially damaging multiple-dose chemotherapy, the difference in survival was striking, with the treatment group not losing a single mouse:

Netrin-1

Conclusion

This study identifies Netrin-1 as a regulator of BM niche health and HSC fitness that at least partially works by restoring DNA damage responses. This discovery might prove important for protecting patients from the harms of chemotherapy and improving HSC transplantation, and it might also apply to the wider context of aging.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Study: Waist-to-Hip Ratio Predicts Mortality Better Than BMI

A new study suggests that waist-to-hip ratio (WHR) has a more linear correlation with all-cause mortality than either body mass...

Restoring Heart Regeneration With a Metabolic Switch

In a recent article in Nature, researchers have restored cardiac regeneration to adult mice by disabling fatty acid oxidation, discovering...

Human Clinical Trials of NMN for Safety and Effectiveness

In a recent paper, researchers reviewed the literature for human clinical trials that address NMN's safety and anti-aging effects [1]....

Lifespan News – Elon Musk and the Living Forever Curse

On this episode of Lifespan News, Ryan O'Shea ruminates on Elon Musk's statement on living forever being a curse rather...

Literature

[1] Ramalingam, P., Gutkin, M. C., Poulos, M. G., Tillery, T., Doughty, C., Winiarski, A., … & Butler, J. M. (2023). Restoring bone marrow niche function rejuvenates aged hematopoietic stem cells by reactivating the DNA Damage Response. Nature Communications, 14(1), 2018.

[2] LΓ³pez-OtΓ­n, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194-1217.

[3] Brunet, A., Goodell, M. A., & Rando, T. A. (2022). Ageing and rejuvenation of tissue stem cells and their niches. Nature Reviews Molecular Cell Biology, 1-18.

[4] Ho, Y. H., & MΓ©ndez-Ferrer, S. (2020). Microenvironmental contributions to hematopoietic stem cell aging. Haematologica, 105(1), 38.

CategoryNews
About the author
Arkadi Mazin

Arkadi Mazin

Arkadi is a seasoned journalist and op-ed author with a passion for learning and exploration. His interests span from politics to science and philosophy. Having studied economics and international relations, he is particularly interested in the social aspects of longevity and life extension. He strongly believes that life extension is an achievable and noble goal that has yet to take its rightful place on the very top of our civilization’s agenda – a situation he is eager to change.
No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.